Thromb Haemost 2023; 123(04): 482-486
DOI: 10.1055/a-2002-1931
SARS-CoV-2 Vaccination: Long-Term Follow-Up of Pre-existing and De Novo Immune Thrombocytopenia
1
Division of Hematology and Medical Oncology, New York Presbyterian Hospital – Weill Cornell Medicine, New York, New York, United States
,
James B. Bussel
1
Division of Hematology and Medical Oncology, New York Presbyterian Hospital – Weill Cornell Medicine, New York, New York, United States
2
Division of Pediatric Hematology/Oncology, New York Presbyterian Hospital – Weill Cornell, New York, New York, United States
,
Eun Ju Lee
1
Division of Hematology and Medical Oncology, New York Presbyterian Hospital – Weill Cornell Medicine, New York, New York, United States
› Institutsangaben
